what myeloma patients need to know about bispecific antibodies
Published 1 year ago • 37 plays • Length 5:58Download video MP4
Download video MP3
Similar videos
-
1:55
bispecific antibodies for myeloma | patient eligibility requirements
-
3:25
what should myeloma patients know about bispecific antibodies?
-
1:52
how is bispecific antibody therapy changing myeloma care?
-
9:34
targeting of myeloma disease progression and bispecific antibody advantages
-
2:16
what is the role of bispecific antibody therapies in future myeloma care?
-
25:45
care partners | what should you know about the bispecific antibody treatment for myeloma?
-
4:26
what are bispecific antibodies?
-
1:13
what is the role of bispecific antibody therapy in the future of myeloma care?
-
2:23
what you should know about myeloma clinical trial participation
-
4:02
what’s the latest in emerging myeloma research?
-
1:33
how has bispecific antibody therapy impacted myeloma care?
-
0:53
what do myeloma patients need to know about immune-based therapies?
-
6:37
understanding myeloma testing and monitoring | an overview
-
1:01:20
your path to empowerment: multiple myeloma
-
14:00
what are bispecific antibodies? #myeloma
-
35:37
thrive | considering car t-cell therapy for myeloma? what you should know
-
3:53
understanding myeloma | how you can collaborate in your care
-
3:38
will myeloma patients need fewer biopsies in the future?
-
0:59
what is the role of an immune system in a myeloma patient? #myeloma